CD4 and gastric cancer: For instance, Nagase et al. observed an increased expression of ICOS in CD4+FOXP3+ TILs with the increase in the stage of gastric cancers, and the elevated expression of ICOS in CD4+FOXP3+ TILs was negatively correlated with relapse-free survival time (136).